D
BioMark Diagnostics Inc. BUX
CNSX
Recommendation
Prev Close
$0.25
Volume
--
Avg Vol (90D)
5,434
Market Cap
$16.00M
Dividend & Yield
--
52-Week Range
$0.18 - $0.305
P/E (TTM)
--
EPS (TTM)
-$0.0131
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$113.10K
EBITDA (TTM)
-$1.39M
EBIT (TTM)
-$1.40M
Net Income (TTM)
-$1.39M
Balance Sheet
Total Assets (Q)
$609.30K
Total Debt (Q)
$1.04M
Total Liabilities (Q)
$1.37M
Book Value Per Share (Q)
-$0.0084
Cash Flow
Cash from Operations (TTM)
-$624.90K
Cash from Investing (TTM)
-$2.70K
Cash from Financing (TTM)
$460.70K
Net Change in Cash (TTM)
-$166.80K
Filings
Filing Date
Saturday, March 1, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Jul 21 and 25 (est)
Price History
Loading...
Beta
0.24
7-Day Total Return
0.00%
30-Day Total Return
4.17%
60-Day Total Return
11.11%
90-Day Total Return
28.21%
Year to Date Total Return
25.00%
1-Year Total Return
-16.67%
2-Year Total Return
0.00%
3-Year Total Return
13.64%
5-Year Total Return
92.31%
52-week Low
Nov 21, 2024 - $0.18
52-week High
Apr 26, 2024 - $0.305
Valuation
Market Cap
$16.00M - Nano Cap
Enterprise Value
$17.07M
Price/Sales (TTM)
2,500.00
Price/Book (Q)
-29.76
Dividends and Shares
Shares Outstanding
885.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biomarkdiagnostics.com
Phone Number
604 370 0779
Address
3851 Shell Road
Richmond, BC V6X 2W2
Country
Canada
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel... more